BATS BZX Real-Time Price
As of 1:35pm ET
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 16.63, with a high estimate of 23.25 and a low estimate of 10.00. The median estimate represents a +326.28% increase from the last price of 3.90.
The current consensus among 2 polled investment analysts is to Buy stock in InVivo Therapeutics Holdings Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.